No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Why Levi Strauss Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Piper Sandler Initiates Karyopharm Therapeutics(KPTI.US) With Buy Rating, Announces Target Price $15
Karyopharm Therapeutics (KPTI) Receives a Buy From Piper Sandler
Baird Maintains Outperform on Karyopharm Therapeutics, Lowers Price Target to $54
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)